LeMaitre Vascular Inc.

86.28
1.61 (1.90%)
At close: Apr 17, 2025, 3:59 PM
86.36
0.09%
After-hours: Apr 17, 2025, 04:38 PM EDT
1.90%
Bid 78.02
Market Cap 1.95B
Revenue (ttm) 219.86M
Net Income (ttm) 44.04M
EPS (ttm) 1.93
PE Ratio (ttm) 44.7
Forward PE 35.06
Analyst Buy
Ask 110
Volume 181,739
Avg. Volume (20D) 224,412
Open 83.75
Previous Close 84.67
Day's Range 83.75 - 86.92
52-Week Range 62.39 - 109.58
Beta 0.88

About LMAT

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vas...

Sector Healthcare
IPO Date Oct 19, 2006
Employees 651
Stock Exchange NASDAQ
Ticker Symbol LMAT
Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $100, which is an increase of 15.90% from the latest price.

Stock Forecasts

Next Earnings Release

LeMaitre Vascular Inc. is scheduled to release its earnings on May 1, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-8.07%
LeMaitre Vascular shares are trading lower after B... Unlock content with Pro Subscription
1 month ago
-3.05%
LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q4 sales results.